Glutathione IV Therapy in Atlanta
Glutathione is an antioxidant made naturally in the body. IV administration delivers glutathione directly into your bloodstream, bypassing the digestive system.
IV glutathione has gained attention for antioxidant support and general wellness. Its role in any specific condition has not been established in controlled clinical trials.

Overview
Glutathione exists in reduced (GSH) and oxidized (GSSG) forms, with the GSH/GSSG ratio serving as a critical indicator of cellular redox status. The unique gamma-peptide bond between glutamate and cysteine protects it from degradation by most peptidases. The cysteine thiol group (-SH) is responsible for glutathione's antioxidant properties and enables its role in conjugation reactions.

Chemical structure & Properties
- Molecular Formula: C₁₀H₁₇N₃O₆S
- Molecular Weight: 307.32 Da
- Structure: γ-L-Glutamyl-L-cysteinyl-glycine (Glu-Cys-Gly)
- Chemical Class: Tripeptide thiol
- Stability: Sensitive to oxidation; stabilized formulations required for IV use
Mechanism of Action
Safety Profile and Considerations
Regulatory Status and
Clinical Use
FDA Status
Not FDA-approved specifically for IV therapeutic use; employed off-label by healthcare providers
Availability
Available through compounding pharmacies under physician prescription
Quality Assurance
Patients should ensure pharmaceutical-grade formulations from reputable, quality-controlled sources
Clinical Considerations
The Paragon Method: Step-by-Step
Administration and Treatment
- Route: Intravenous infusion achieves significantly higher plasma concentrations than oral administration
- Infusion Rate: 15-30 minutes recommended for optimal tolerance
- Frequency: Varies from single sessions to regular protocols (weekly, bi-weekly, or monthly)
- Duration: Depends on therapeutic goals and clinical response

Patient Selection
Appropriate candidates are determined at a clinical evaluation, including a full medication review.

Optimization Strategies
- Adequate hydration before and after treatment
- Nutritional support (selenium, B vitamins, sulfur-containing amino acids)
- Lifestyle modifications reducing oxidative stress
- Avoidance of alcohol during treatment periods

Monitoring
- Regular assessment of therapeutic response
- Monitoring for adverse effects
- Periodic evaluation of oxidative stress markers when indicated
- Treatment protocol adjustment based on clinical response


Conclusion
Glutathione is an antioxidant made naturally in the body. IV administration delivers it directly into the bloodstream, after a provider review.
Robust human evidence for IV glutathione is limited. Your provider reviews your history and medications first, and will explain what the current evidence does and does not show.
References
Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8-12.
Sechi G, et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(7):1159-1170.
Richie JP, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263.
Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009;24(7):979-983.
Wu G, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489-492.
Forman HJ, et al. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. Glutathione IV therapy is used off-label and has not been approved by the FDA specifically for the treatment of any disease. Patients should consult with qualified healthcare providers before considering any IV therapy. The content reflects current scientific literature and clinical practice as of 2025. Individual results may vary, and treatment appropriateness should be determined on a case-by-case basis by licensed medical professionals.